Get started
Silence Therapeutics, Plc.Silence Therapeutics, Plc.Silence Therapeutics, Plc.

Silence Therapeutics, Plc.

No trades
OverviewFinancialsNewsDocumentsCommunityTechnicalsSeasonals

Chart


Full chart

Key stats


Market capitalization
‪214.44 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
—
Net income (FY)
‪−45.31 M‬ USD
Revenue (FY)
‪43.26 M‬ USD
Shares float
‪93.81 M‬
Beta (1Y)
1.48

Employees


Employees (FY)
116
Change (1Y)
+7 +6.42%
Revenue / Employee (1Y)
‪372.91 K‬ USD
Net income / Employee (1Y)
‪−390.59 K‬ USD

About Silence Therapeutics, Plc.


Sector
Commercial Services
Industry
Miscellaneous Commercial Services
CEO
Iain Gladstone Ross
Website
silence-therapeutics.com
Headquarters
London
Founded
1994
IPO date
Jan 5, 2010
Identifiers
2
ISIN GB00B9GTXM62
Silence Therapeutics Plc engages in the discovery, delivery, and development of ribonucleic acid (RNA) therapeutics. It also develops medicines by harnessing the body's natural mechanism of RNA interference within its cells. The company was founded on November 18, 1994 and is headquartered in London, the United Kingdom.

Check out other big names from the same industry as SLNCF.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of SLNCF is 1.60 USD — it has increased by 6.67% in the past 24 hours. Watch Silence Therapeutics, Plc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Silence Therapeutics, Plc. stocks are traded under the ticker SLNCF.
SLNCF reached its all-time high on Apr 25, 2022 with the price of 46.50 USD, and its all-time low was 0.01 USD and was reached on Jul 5, 2012. View more price dynamics on SLNCF chart.
See other stocks reaching their highest and lowest prices.
SLNCF stock is 6.25% volatile and has beta coefficient of 1.48. Track Silence Therapeutics, Plc. stock price on the chart and check out the list of the most volatile stocks — is Silence Therapeutics, Plc. there?
Today Silence Therapeutics, Plc. has the market capitalization of ‪226.72 M‬, it has increased by 4.42% over the last week.
Yes, you can track Silence Therapeutics, Plc. financials in yearly and quarterly reports right on TradingView.
SLNCF net income for the last quarter is ‪−20.96 M‬ USD, while the quarter before that showed ‪−27.35 M‬ USD of net income which accounts for 23.38% change. Track more Silence Therapeutics, Plc. financial stats to get the full picture.
No, SLNCF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Feb 14, 2026, the company has 116 employees. See our rating of the largest employees — is Silence Therapeutics, Plc. on this list?
Like other stocks, SLNCF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Silence Therapeutics, Plc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Silence Therapeutics, Plc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Silence Therapeutics, Plc. stock shows the sell signal. See more of Silence Therapeutics, Plc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.